Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2014
10/07/2014US8853415 Modulators of ATP-binding cassette transporters
10/07/2014US8853393 Intermediate for preparing tapentadol or analogues thereof
10/07/2014US8853392 Benzamide mGluR5 positive allosteric modulators and methods of making and using same
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853258 C-linked hydroxamic acid derivatives useful as antibacterial agents
10/07/2014US8853255 3-phenoxymethylpyrrolidine compounds
10/07/2014US8853218 Compounds
10/07/2014US8853215 Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/07/2014US8852846 Salt and photoresist composition comprising the same
10/02/2014WO2014156196A1 Therapeutic agent for type 2 diabetes
10/02/2014US20140296523 Ionic Liquids, The Method For Preparing The Same And Method For Removing Acetylenes From Olefin Mixtures Using The Ionic Liquids
10/02/2014US20140296517 L-Setastine Hydrochloride and Preparation Method Thereof
10/02/2014US20140296343 Non-peptide bdnf neurotrophin mimetics
10/02/2014US20140296287 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
10/02/2014US20140296256 Plasminogen activator inhibitor-1 inhibitor
10/02/2014US20140296249 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
10/02/2014US20140296241 The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain
10/02/2014US20140296240 Substituted aminopropionic derivatives as neprilysin inhibitors
10/01/2014EP2784068A1 Phosphodiesterase 4 inhibitor capable of avoiding vomiting
09/2014
09/30/2014US8846972 Fatty acid acylated salicylates and their uses
09/30/2014US8846929 Substituted-quinoxaline-type piperidine compounds and the uses thereof
09/30/2014US8846739 TGR5 agonists
09/30/2014US8846012 Melanin production inhibitor
09/30/2014CA2763786C Alkanoylamino benzamide aniline hdac inihibitor compounds
09/25/2014WO2014147642A1 Substituted fluoranthene-7-carbonitriles as fluorescent dyes for cell imaging applications
09/25/2014US20140288089 1-(2-phenoxymethylphenyl)piperazine compounds
09/25/2014US20140288077 Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity
09/25/2014US20140288045 Covalent inhibitors of kras g12c
09/25/2014US20140288040 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
09/23/2014US8841483 Compositions useful as inhibitors of voltage-gated sodium channels
09/23/2014US8841459 3-arylamino pyridine derivatives
09/23/2014US8841330 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
09/23/2014US8841290 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs
09/23/2014US8841276 Fulvene and fulvalene analogs and their use in treating cancers
09/23/2014CA2596393C 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions
09/18/2014US20140275108 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
09/18/2014US20140275090 Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
09/18/2014US20140275060 Compounds for the treatment of neurologic disorders
09/18/2014US20140275048 Prodrugs of fumarates and their use in treating various diseases
09/18/2014US20140275037 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
09/18/2014US20140275032 ARYL SULFAMIDE AND SULFAMATE DERIVATIVES AS RORc MODULATORS
09/18/2014US20140271955 Compounds and methods for inducing chondrogenesis
09/18/2014US20140271734 Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
09/16/2014US8835689 Substituted 4-aminocyclohexane derivatives
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835463 Compounds having analgesic and/or immunostimulant activity
09/16/2014US8835419 Substituted anilines as CCR(4) antagonists
09/16/2014US8835418 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
09/11/2014US20140256944 Process for making alkoxylated piperazine compounds
09/11/2014US20140256943 1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256742 Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
09/11/2014US20140256731 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
09/11/2014US20140256729 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
09/11/2014US20140256702 Neprilysin inhibitors
09/11/2014US20140256701 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/11/2014US20140256698 Cathepsin inhibitors
09/10/2014EP2773613A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
09/09/2014US8829201 Electrolyte Formulations
09/09/2014US8829002 Substituted methyl amines, serotonin 5-HT6 receptor antagonists, methods for production and use thereof
09/09/2014CA2774040C 2, 3-dihydro-1h-inden-2-yl urea derivatives and medical uses thereof
09/04/2014US20140249181 Tropolone compounds for treating or preventing retroviral infection
09/04/2014US20140249161 Stilbene analogs and methods of treating cancer
09/04/2014US20140248356 1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment
09/04/2014US20140248355 1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment
09/04/2014US20140245541 Novel oxidation dye precursors
09/03/2014EP2772254A2 Novel Antibacterial Agents
09/02/2014US8822728 Biological buffers with wide buffering ranges
09/02/2014US8822680 Paracyclophane-based ligands, their preparation and use in catalysis
09/02/2014US8822467 Biaryl oxyacetic acid compounds
09/02/2014US8822463 Methylcyclohexane derivatives and uses thereof
09/02/2014US8821592 Oxidation dye precursors
08/2014
08/28/2014WO2014128207A1 Vortioxetine manufacturing process
08/28/2014US20140243352 Methods for treating diabetic complications with carbamoyloxy arylalkanoyl arylpiperazine compounds
08/28/2014US20140243334 Substituted hydoxamic acids and uses thereof
08/28/2014US20140243324 Use of hematopoietic growth factor mimetics
08/28/2014DE102013202252A1 Dünnschichtkondensatoren mit hoher Integrationsdichte Thin film capacitors with high integration density
08/26/2014US8816078 Acidic gas removal by aqueous amine solvents
08/26/2014US8815852 Carbamoyloxy arylalkan arylpiperazine analgesics
08/26/2014CA2653039C Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
08/21/2014WO2014125410A1 N-substituted heterocyclic derivatives as kinase inhibitors
08/21/2014WO2014125075A1 Albicidin derivatives, their use and synthesis
08/21/2014US20140235650 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
08/21/2014US20140235636 N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
08/20/2014EP2766339A1 The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain
08/19/2014US8809591 Process for the manufacture of TMHQ
08/19/2014US8809381 Highly selective sigma receptor ligands
08/19/2014US8809332 Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone
08/19/2014US8809280 Therapeutic peptides
08/19/2014CA2647445C N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
08/19/2014CA2623350C Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
08/14/2014WO2014122670A1 Carbodithioates with spermicidal activity and process for preparation thereof
08/14/2014WO2014122303A1 Glucan synthase inhibitors
08/14/2014WO2014121884A1 Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis
08/14/2014US20140228357 Novel compounds as hif-1alphainhibitors and manufacturing process thereof
08/14/2014DE102013202250A1 Emitterschichten mit einem Matrixmaterial enthaltend asymmetrisch substituierte Guanidinium-Kationen Emitter layers with a matrix material comprising asymmetrically substituted guanidinium cations
08/13/2014CN103980230A 一种制备4-(4-甲基哌嗪-l-甲基)苯甲酰胺的方法 A 4- (4-methyl-piperazin--l- methyl) benzamide was prepared
08/13/2014CN103980229A 一种n-苯基哌嗪的制备方法 One kind n- phenylpiperazine Preparation
08/13/2014CN103980204A 离子液体催化胺类与α,β-不饱和缺电子受体方法 Amines catalyzed by ionic liquid with α, β- unsaturated electron-deficient acceptor method
08/13/2014CN103980195A 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用 Amides phenyl piperazine derivatives and salts in the preparation and application of the treatment of benign prostatic hyperplasia medicine
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 341